Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: A long-term follow-up

Clinical Nephrology

Volumn 43, Issue 2, 1995, Pages 84-88

  Tune, B M ^a   Kirpekar, R ^a   Sibley, R K ^a   Reznik, V M ^a   Griswold, W R ^a   Mendoza, S A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

End stage failure; Nephrotic syndrome; Steroid pulse therapy

Indexed keywords

ALKYLATING AGENT; CHLORAMBUCIL; CREATININE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CREATININE CLEARANCE; CREATININE URINE LEVEL; DIALYSIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESISTANCE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PROTEINURIA; RELAPSE; REMISSION;

CHILD, PRESCHOOL; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL; HUMAN; MALE; METHYLPREDNISOLONE; NEPHROTIC SYNDROME; PREDNISONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0028817502     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)